SG Americas Securities’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Buy |
37,328
+12,963
| +53% | +$151K | ﹤0.01% | 1598 |
|
|
2025
Q1 | $181K | Sell |
24,365
-21,579
| -47% | -$160K | ﹤0.01% | 2319 |
|
|
2024
Q4 | $275K | Buy |
45,944
+4,799
| +12% | +$28.7K | ﹤0.01% | 1642 |
|
|
2024
Q3 | $211K | Buy |
41,145
+19,478
| +90% | +$99.9K | ﹤0.01% | 2169 |
|
|
2024
Q2 | $78K | Buy |
+21,667
| New | +$78K | ﹤0.01% | 2267 |
|
|
2024
Q1 | – | Sell |
-70,571
| Closed | -$346K | – | 2530 |
|
|
2023
Q4 | $346K | Buy |
70,571
+11,851
| +20% | +$58.1K | ﹤0.01% | 1535 |
|
|
2023
Q3 | $320K | Buy |
58,720
+18,658
| +47% | +$102K | ﹤0.01% | 1869 |
|
|
2023
Q2 | $269K | Sell |
40,062
-36,792
| -48% | -$247K | ﹤0.01% | 1458 |
|
|
2023
Q1 | $679K | Buy |
76,854
+47,892
| +165% | +$423K | 0.01% | 1343 |
|
|
2022
Q4 | $221K | Buy |
28,962
+5,339
| +23% | +$40.7K | ﹤0.01% | 1913 |
|
|
2022
Q3 | $168K | Sell |
23,623
-27,055
| -53% | -$192K | ﹤0.01% | 2182 |
|
|
2022
Q2 | $410K | Buy |
50,678
+25,439
| +101% | +$206K | ﹤0.01% | 1941 |
|
|
2022
Q1 | $350K | Buy |
25,239
+1,363
| +6% | +$18.9K | ﹤0.01% | 1886 |
|
|
2021
Q4 | $670K | Buy |
23,876
+13,262
| +125% | +$372K | ﹤0.01% | 1761 |
|
|
2021
Q3 | $361K | Buy |
10,614
+2,969
| +39% | +$101K | ﹤0.01% | 2553 |
|
|
2021
Q2 | $312K | Sell |
7,645
-18,656
| -71% | -$761K | ﹤0.01% | 1940 |
|
|
2021
Q1 | $1.06M | Buy |
26,301
+24,283
| +1,203% | +$978K | 0.01% | 1357 |
|
|
2020
Q4 | $119K | Sell |
2,018
-8,964
| -82% | -$529K | ﹤0.01% | 2595 |
|
|
2020
Q3 | $534K | Buy |
+10,982
| New | +$534K | ﹤0.01% | 1327 |
|
|
2020
Q1 | – | Sell |
-6,520
| Closed | -$195K | – | 2830 |
|
|
2019
Q4 | $195K | Buy |
+6,520
| New | +$195K | ﹤0.01% | 2148 |
|
|
2019
Q3 | – | Sell |
-15,000
| Closed | -$724K | – | 2436 |
|
|
2019
Q2 | $724K | Buy |
+15,000
| New | +$724K | 0.01% | 1463 |
|